These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9625849)

  • 1. Single-dose etoposide in advanced pancreatic and biliary cancer, a phase II study.
    Ekstrom K; Hoffman K; Linne T; Eriksson B; Glimelius B
    Oncol Rep; 1998; 5(4):931-4. PubMed ID: 9625849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.
    Glimelius B; Hoffman K; Sjödén PO; Jacobsson G; Sellström H; Enander LK; Linné T; Svensson C
    Ann Oncol; 1996 Aug; 7(6):593-600. PubMed ID: 8879373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.
    Souhami RL; Spiro SG; Rudd RM; Ruiz de Elvira MC; James LE; Gower NH; Lamont A; Harper PG
    J Natl Cancer Inst; 1997 Apr; 89(8):577-80. PubMed ID: 9106647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma.
    Maiello E; Gebbia V; Giuliani F; Testa A; Giotta F; Gebbia N; Colucci G
    Clin Ter; 1998; 149(5):351-5. PubMed ID: 10052247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral etoposide for patients with advanced adenocarcinoma of the pancreas.
    Thomas E; Dumas P; Ajani JA
    Invest New Drugs; 1998-1999; 16(4):333-5. PubMed ID: 10426667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience.
    Li J; Merl M; Lee MX; Kaley K; Saif MW
    Expert Opin Drug Saf; 2010 Mar; 9(2):207-13. PubMed ID: 20095915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.
    Evans SR; Krown SE; Testa MA; Cooley TP; Von Roenn JH
    J Clin Oncol; 2002 Aug; 20(15):3236-41. PubMed ID: 12149296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of etoposide for urogenital tumors].
    Kinjo T; Murase T; Aota Y; Shimoji T; Mitsuya H
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1267-71. PubMed ID: 4004290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of raltitrexed (Tomudex) in advanced pancreatic and biliary carcinoma.
    François E; Hebbar M; Bennouna J; Mayeur D; Perrier H; Dorval E; Martin C; Bourgeois H; Barthélemy P; Douillard JY
    Oncology; 2005; 68(4-6):299-305. PubMed ID: 16020956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).
    Alici S; Saip P; Eralp Y; Aydiner A; Topuz E
    Am J Clin Oncol; 2003 Aug; 26(4):358-62. PubMed ID: 12902885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
    Schwartsmann G; Sprinz E; Kromfield M; Kalakun L; Sander E; Prolla G; Di Leone L; Gerhardt L; Mans DR
    J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of etoposide in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.
    Thigpen T; Blessing JA; Yordan E; Valea F; Vaccarello L
    Gynecol Oncol; 1996 Oct; 63(1):120-2. PubMed ID: 8898180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.
    Pfeiffer P; Rytter C; Madsen EL; Moeholt K; Hansen O; Bentzen S; Palshof T; Rose C
    J Natl Cancer Inst; 1997 Dec; 89(24):1892-3. PubMed ID: 9414178
    [No Abstract]   [Full Text] [Related]  

  • 14. A retrospective analysis of the activity and safety of oral Etoposide in heavily pretreated metastatic breast cancer patients.
    Valabrega G; Berrino G; Milani A; Aglietta M; Montemurro F
    Breast J; 2015; 21(3):241-5. PubMed ID: 25772707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer.
    Planting A; Kho S; van der Burg M; Goey H; Schellens J; van den Bent M; van der Gaast A; de Boer-Dennert M; Stoter G; Verweij J
    Cancer Chemother Pharmacol; 1997; 40(4):347-52. PubMed ID: 9225954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage therapy with oral etoposide in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gedlicka C; Kornfehl J; Turhani D; Burian M; Formanek M
    Cancer Invest; 2006; 24(3):242-5. PubMed ID: 16809151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of prolonged ambulatory infusion carboplatin with oral etoposide showing activity in prostate cancer.
    Olver IN; Stephenson J; Schulze D
    Cancer Chemother Pharmacol; 2000; 46(4):338-41. PubMed ID: 11052632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral etoposide in patients with hematological malignancies: a clinical and pharmacokinetic study.
    Osby E; Liliemark E; Björkholm M; Liliemark J
    Med Oncol; 2001; 18(4):269-75. PubMed ID: 11918453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.
    Morris M; Brader KR; Burke TW; Levenback CF; Gershenson DM
    Gynecol Oncol; 1998 Aug; 70(2):215-8. PubMed ID: 9740693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma.
    Kruth J; Nissen J; Ernst T; Kripp M; Lukan N; Merx K; Hofmann WK; Hochhaus A; Hofheinz RD
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1845-51. PubMed ID: 20224968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.